Precipio Inc (NASDAQ:PRPO) stock had an amazing day as the stock topped the top percentage winner on Monday following the news of the launch of rapid covid-19 antibody test launch on Amazon.
What’s more interesting in today’s session is that after opening with a marginal gain of about 6%, the stock had a trending day as it kept on rising gradually. The stock ended the session higher by 172% at the highest point of the day of $4.95. Moreover, PRPO stock is up another 35% in after-hours sessions at $6.70.
The 20-minute antibody test, which is made by Nirmidas Biotech in Palo Alto, Calif., was the first U.S.-based test to receive emergency use authorization by the U.S. Food and Drug Administration for point-of-care, the company said in a statement.
The sale of the test is only available to qualified medical point-of-care providers. That means the average customers can just go buy one of the coronavirus tests for themselves.
PRPO stock must be on your watchlist for Tuesday as the stock ended with solid momentum today.
Editor and Computer Expert
A hardcore tech enthusiast and computer expert Uson Abdilazhanov who holds a degree in communications started writing in his personal blogs since 2012. That time he was interested in the technical part of the computer. But now the software aspect plays an important role in his career. Currently, he runs a PC building and repairing shop which helps a lot of designers and gamers who always like to try new things.